Inhaled biopharmaceutical drug development: nonclinical considerations and case studies

Author： McElroy Mary C.   Kirton Chris   Gliddon Dan   Wolff Ron K.  

Publisher： Informa Healthcare

ISSN： 1091-7691

Source： Inhalation Toxicology, Vol.25, Iss.4, 2013-03, pp. : 219-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sampling design considerations for demographic studies: a case of colonial seabirds

By  

Ecological Applications, Vol. 19, Iss. 1, 2009-01 ,pp. : 55-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

CONSIDERATIONS IN EVALUATING AND SELECTING MODELS FOR TMDL DEVELOPMENT–A CASE STUDY OF STEAMBOAT CREEK

By Garvey Elisa   Chavan Seema   McDonald Steve   Jobes Tom   Donigian Tony   Weintraub Laura   Chen Carl   Dennis Greg  

Proceedings of the Water Environment Federation, Vol. 2003, Iss. 4, 2003-01 ,pp. : 461-485

Water Environment Federation

Access to resources Recommend Favorite

Comparative pulmonary response to inhaled nanostructures: considerations on test design and endpoints

By Pauluhn Jürgen  

Inhalation Toxicology, Vol. 21, Iss. 1, 2009-07 ,pp. : 40-54

Informa Healthcare

Access to resources Recommend Favorite

The Research on International Development Path of China’s Marine Biopharmaceutical Industry

By Fu Xiu-Mei   Jiang Shan-Shan   Wang Na   Wang Shi-Qi   Wang Chang-Yun  

Sustainability, Vol. 10, Iss. 2, 2018-02 ,pp. : 399-399

MDPI

Access to resources Recommend Favorite

‘Short Cut' Techniques to Incorporate Environmental Considerations into Project Appraisal: An Exploration Using Case Studies

By Knowler Duncan  

Journal of Environmental Planning and Management, Vol. 48, Iss. 5, 2005-09 ,pp. : 747-770

Routledge Ltd

Access to resources Recommend Favorite